← Back to Search

DBT intervention for Antisocial Behavior (DBT-ASPD Trial)

N/A
Waitlist Available
Led By Barry Rosenfeld, PhD
Research Sponsored by Fordham University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Over 18, English speaking, Participating in RISE Court program
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This pilot study is intended to adapt and refine an intervention grounded in the principles of Dialectical Behavior Therapy, for the treatment of repeat criminal offenders with antisocial personality disorder. This study will be open to individuals participating in an intensive supervision program operated by the U.S. District Court of the Southern District of New York (the RISE Court program).

Eligible Conditions
  • Antisocial Behavior
  • Antisocial Personality Disorder

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Completion of the treatment program
Secondary study objectives
Distress tolerance
Emotion regulation
Impulsivitity
+2 more

Side effects data

From 2012 Phase 4 trial • 91 Patients • NCT00533117
6%
Hospitalization or ED visitn
100%
80%
60%
40%
20%
0%
Study treatment Arm
Dialectical Behavior Therapy With Fluoxetine
Supportive Therapy With Fluoxetine
Dialectical Behavior Therapy With Placebo
Supportive Therapy With Placebo

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: DBT interventionExperimental Treatment1 Intervention
Adaptation of Dialectical Behavior Therapy designed for repeat criminal offenders at high risk of reoffense.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dialectical Behavior Therapy
2016
Completed Phase 4
~960

Find a Location

Who is running the clinical trial?

Fordham UniversityLead Sponsor
20 Previous Clinical Trials
4,046 Total Patients Enrolled
Barry Rosenfeld, PhDPrincipal InvestigatorFordham University
2 Previous Clinical Trials
200 Total Patients Enrolled
~15 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top